If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
125.00    0.00 (0.00%)
Bid:
118.00
Ask:
124.50
Spread: 6.50 (5.508%)
Market Cap: £98.09m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Update

12 Jan 2023 07:00

RNS Number : 4516M
Xaar PLC
12 January 2023
 

 

 

XAAR plc 

 

TRADING UPDATE

 

Xaar plc ("Xaar", "the Group" or "the Company"), the leading inkjet printing technology group, today announces a trading update for the year ended 31 December 2022.

 

TRADING

Strong revenue growth and full-year profitability

· Revenue for the period is expected to be approximately £74 million (2021: £59.3 million), representing year on year growth of 24% driven by a combination of organic growth (9%) and acquisitions

 

· The Group is expected to deliver an on track adjusted profit for the year

 

· During 2022 the Group continued to invest in working capital and infrastructure development and in March completed the acquisition of Megnajet

 

 

Further operational and strategic progress

· Further progress was made throughout the year in implementing the strategy to achieve long-term profitable growth

 

· Successful launch of Aqueous printhead product in November 2022 as planned, and on budget, is receiving strong customer engagement

 

· Factory reorganisation commenced in December and is progressing well and on schedule for completion by March 2023. This project is expected to deliver increased efficiency, reduce power usage, and reduce costs

 

· The integration of recent acquisitions (FFEI and Megnajet) has been completed successfully and both are contributing positively to Group results 

 

· Continued progress at EPS delivered its best performance to date with revenue growth of 36%

 

 

Challenging macro conditions expected to continue into 2023

· Sales volumes in the Printhead business continue to be affected by the uncertainty in China, which is expected to continue in the short term as Covid cases increase. At this stage it remains unclear when normal levels of business will return

 

· We have maintained our policy of increased investment in inventory to ensure availability of product during the factory reorganisation in Q1 2023 and the remainder of the year

 

BALANCE SHEET AND LIQUIDITY

· The Group remains well capitalised with a strong balance sheet with a net cash position as at 31 December 2022 of £8.6 million

 

 

John Mills, Chief Executive Officer, commented:

"I am hugely proud of the team in delivering a strong performance and making further progress with our strategy. We expect to deliver strong profitable revenue growth and the important milestone of achieving full year profitability representing great progress against our plan and remain well positioned for the business to achieve its exciting potential.

Aquinox has been successfully launched and is already being well received by our customers. With the operational improvements now well underway, notwithstanding the challenging external environment, the business is in good shape to continue to make further progress over the long term."

 

 

 

 

 

 

 

 

 

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Tulchan Communications

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFIFWFEDSEDF
Date   Source Headline
3rd Oct 20164:33 pmRNSTotal Voting Rights
29th Sep 20169:25 amRNSBoard Changes
1st Sep 201610:44 amRNSTotal Voting Rights
26th Aug 201611:44 amRNSGrant of Options
24th Aug 20167:00 amRNS2016 Interim Results
1st Aug 20162:07 pmRNSTotal Voting Rights
13th Jul 20167:00 amRNSScheduled Trading Statement
12th Jul 20166:02 pmRNSHolding(s) in Company
1st Jul 201610:56 amRNSBlock listing Interim Review
1st Jul 201610:53 amRNSTotal Voting Rights
1st Jul 20169:32 amRNSNotice of Scheduled Trading Statement
1st Jul 20167:00 amRNSXAAR AQUIRES ENGINEERED PRINTING SOLUTIONS
2nd Jun 20163:00 pmRNSLAUNCH OF PRINTHEAD FAMILY & STRATEGIC PARTNERSHIP
1st Jun 20163:39 pmRNSTotal Voting Rights
19th May 20163:01 pmRNSResult of AGM - Replacement
18th May 20163:03 pmRNSResult of AGM
13th May 201610:09 amRNSGrant of Options
9th May 201612:42 pmRNSDirector Shareholding
4th May 20167:00 amRNSAppointment of Non-Executive Director
29th Apr 20169:00 amRNSTotal Voting Rights
15th Apr 20169:59 amRNSDirector/PDMR Shareholding - SIP Purchase
5th Apr 20163:17 pmRNSHolding(s) in Company
4th Apr 20161:58 pmRNSGrant of Options
1st Apr 20161:50 pmRNSHolding(s) in Company
1st Apr 20169:03 amRNSTotal Voting Rights
22nd Mar 201612:04 pmRNSXAAR LAUNCHES NEW FAMILY OF PRINTHEADS
18th Mar 201612:07 pmRNSDirector/PDMR Shareholding
16th Mar 20167:00 amRNS2015 Full Year Results, 2020 Vision
7th Mar 201610:00 amRNSHolding(s) in Company
1st Mar 201610:13 amRNSTotal Voting Rights
1st Feb 20162:41 pmRNSTotal Voting Rights
22nd Jan 201612:02 pmRNSHolding(s) in Company
18th Jan 20166:16 pmRNSHolding(s) in Company
13th Jan 20167:00 amRNSScheduled Trading Statement
6th Jan 20167:00 amRNSXAAR STRENGTHENS ITS 3D PRINTING BUSINESS
4th Jan 20164:12 pmRNSBlocklisting Interim Review
4th Jan 20163:27 pmRNSTotal Voting Rights
17th Dec 201510:07 amRNSDirector Shareholding
11th Dec 20157:00 amRNSBoard Changes
9th Dec 20154:56 pmRNSHolding(s) in Company
1st Dec 20155:52 pmRNSTotal Voting Rights
25th Nov 20153:46 pmRNSHolding(s) in Company
16th Nov 20159:50 amRNSHolding(s) in Company
9th Nov 20151:53 pmRNSDirector/PDMR Shareholding
4th Nov 20157:00 amRNSInterim Management Statement
2nd Nov 20152:43 pmRNSTotal Voting Rights
7th Oct 20157:00 amRNSNotice of Trading Statement
1st Oct 201510:42 amRNSTotal Voting Rights
1st Sep 20152:43 pmRNSTotal Voting Rights
28th Aug 20153:44 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.